Funding Programs

Medical Research Program

In 2009, Richard Rainwater was diagnosed with Progressive Supranuclear Palsy (PSP), a rare neurodegenerative disease that causes serious problems with walking, balance, and vision. PSP is one of several neurodegenerative diseases classified as a tauopathy due to the accumulation of tau protein in the brain. Determined to help others suffering from PSP, Mr. Rainwater assembled a team of the leading physicians and researchers from around the world and charged them with working together to find a cure for PSP and other tauopathies.

Medical Research Giving 2021-2022

$35,027,563

Our medical research strategy is to use
philanthropic dollars to address pressing gaps
in the field of primary tauopathies. These gaps include basic research, drug discovery, clinical trials, or new talent that might be overlooked by traditional sources of funding.

trophy

Medical Research Grant Recipients

To learn more about our grant recipients and partnerships, please view the latest annual report.

2021-2022 Annual Report

Areas of Focus

Tau Consortium^™

The Tau Consortium’s goal is to foster high-impact, collaborative networks of scientists who can help us to better understand tauopathies and guide development of effective treatments for patients.

Learn More

The Rainwater Prize^TM

The Rainwater Prize Program, which
launched in 2018, recognizes scientific
progress toward new treatments for
neurodegenerative diseases associated with the accumulation of tau protein in the brain.

Learn More

Tauopathy Challenge Workshop^TM

Each Tauopathy Challenge Workshop brings together a brilliant cohort of researchers with diverse specialties and backgrounds in pursuit of answers to one of the most enigmatic neurodegenerative conditions.

Learn More

mail